AGIO: Message Board for Agios Pharmaceuticals, Inc. - InvestorVillage


Agios Pharmaceuticals, Inc.

  AGIO website

AGIO   /  Message Board

 
BOARD

GROUPS
 





 
Loading...
 
 
--




Keyword
Subject
Between
and
Rec'd By
Authored By
Minimum Recs
  
MSG # SUBJECT TYPE AUTHOR SENTIMENT RECS DATE POSTED
388 Agios Announces Clinical Proof-of-Concept in Phase 2a Trial of AG-946 for the Treatme GN jerrykrause 0 11/21/2023 4:41:58 PM
387 Agios Announces Publication of Phase 2 Data in The Lancet Demonstrating Safety and Efficacy of PYRUKYNDŽ (mitapivat) in Non-transfusion-dependent ?- and ?-Thalassemia GN jerrykrause 1 8/13/2022 1:13:49 PM
386 Agios Announces Publication of Phase 3 ACTIVATE Study in New England Journal of Medicine Demonstrating Benefits of PYRUKYNDŽ (mitapivat) for Adults with Pyruvate Kinase Deficiency GN jerrykrause 0 4/16/2022 12:07:57 PM
385 Agios strategy shift pays off with FDA approval of first drug for rare anemia GN jerrykrause 0 2/19/2022 12:40:07 PM
384 Agios wins FDA approval for drug to treat rare form of anemia GN jerrykrause 0 2/19/2022 12:39:25 PM
383 Agios Announces FDA Acceptance and Priority Review of New Drug Application for Mitapivat for Treatment of Adults with Pyruvate Kinase Deficiency GN jerrykrause 1 8/18/2021 5:32:16 PM
382 Agios Highlights 2021 Milestones to Accelerate and Expand Its Genetically Defined Disease Portfolio and Drive Near- and Long-Term Value Creation GN jerrykrause 3 1/13/2021 6:42:26 PM
381 Agios Provides Update on 2016 Collaboration Agreement with Celgene, a Wholly Owned Subsidiary of Bristol Myers Squibb GN jerrykrause 1 3/27/2020 10:35:58 AM
380 Agios Announces Agios 2025 Strategic Vision and Highlights 2020 Milestones GN jerrykrause 3 1/14/2020 12:23:57 PM
379 AGIO gets Breakthrough Therapy Designation (BTD)... GN JoeFlow 0 3/27/2019 6:01:20 PM
Previous 270 Messages Top of Message List Post Message Go to Msg #  




Financial Market Data provided by
.
Loading...